GILD|Gilead Sciences, Inc.
Gilead Sciences, Inc. is a global biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company primarily focuses on developing and marketing therapeutics for life-threatening diseases, with core strengths in virology and oncology. Its product portfolio includes treatments for HIV, viral hepatitis, influenza, COVID-19, and various cancers, utilizing advanced therapeutic approaches such as small molecules, cell therapies, and antibody-drug conjugates. Gilead serves healthcare providers and patients worldwide through a direct commercial infrastructure, generating revenue primarily from product sales of its approved medicines. The company operates a research-driven business model that involves significant investment in clinical development, strategic collaborations, and acquisitions to expand its pipeline and address serious health challenges.